international
Why France's national medication agency is sanctioning two pharmaceutical companies for covert advertising
Why this matters: an international story with cross-border implications worth tracking.
France's National Agency for the Safety of Medicine and Health Products (ANSM) has ruled that the campaigns led by Novo Nordisk and Eli Lilly, which were presented as awareness initiatives, amounted to promotion of their products. Such advertising is forbidden in France.
Read full story on Le Monde (English) → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Le Monde (English) alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop